Skip to main content
  • Saved

Diagnosis of osteoporosis in statin-treated patients is dose-dependent

Diagnosis of osteoporosis in statin-treated patients is dose-dependent

Source : https://ard.bmj.com/content/78/12/1706

Objective Whether HMG-CoA-reductase inhibition, the main mechanism of statins, plays a role in the pathogenesis of osteoporosis, is not entirely known so far. Consequently, this study was set out to investigate the relationship of different kinds and dosages of statins with osteoporosis, hypothesising that the inhibition of the synthesis of cholesterol could influence sex-hormones and therefore the diagnosis of osteoporosis.

Sign In or Register Today to Access This Content